liver failure, and disseminated intravascular coagulopathy. 2 Unlike the epidemiology of dengue in many developing countries, the resurgence of dengue in Singapore has been associated with an adult predominance with very low incidence in children. 3 Dengue virus infections are rarely fatal in adults, although fatal infections do occur. 4 Since 2003, dengue cases have risen dramatically in Singapore. In 2004, there was a record 9459 cases notified with eight deaths, with the highest incidence of disease in young adults aged 15-24 years. 5 More than three quarters of all dengue cases in Singapore are hospitalized. 5 In order to better understand the risk factors for mortality and the epidemiology of severe dengue cases in our hospital population, we conducted a case-control study of all dengueassociated deaths within our institution.
Methods
A retrospective case-control study was performed. All cases of dengue-associated mortality in Tan Tock Seng Hospital for the period 1 January to 31 September 2004 were identified through cross matching of hospital discharge data with dengue notification records. Notification of dengue infection to the Ministry of Health is mandatory in Singapore. The study was approved by the institutional review committee of the National Healthcare Group. Tan Tock Seng Hospital (TTSH) is a 1100-bed tertiary care adult hospital serving the central, north, and northeastern adult population of Singaporeareas of known high dengue transmission. 5 All cases of dengue were defined as: (i) a compatible clinical illness with (ii) positive serology (IgM and/or IgG by Dengue Duo Rapid Strip Test, PanBio, Australia) 6 or reverse transcriptase-polymerase chain reaction (RT-PCR) test. Dengue-associated deaths were defined as deaths resulting from, and as a direct consequence of, acute dengue infection. Persons admitted with dengue virus infection during the same month of admission as dengue-associated death cases were randomly selected from the hospital patient database as controls. Five controls were chosen for every dengue-associated death case. The medical records of all cases identified were reviewed. Final disease categorization into dengue fever (DF), dengue hemorrhagic fever (DHF), and dengue shock syndrome (DSS) was based on the World Health Organization's recommended system of classification. 7 Day of illness at admission (day 1 of illness was counted as the day
264
A. Ong et al. of fever onset), demographic, clinical, and laboratory data were collected on standardized data-collection forms. Petechiae, epistaxis, gingival bleeding, or menorrhagia were classified as minor bleeding complications.
Statistical analysis
The Student's t test was used for comparison of continuous variables, and Fisher's exact test was used for comparison of dichotomous variables of mortality-associated dengue cases and those with uncomplicated DF. For data that were not normally distributed, the Mann-Whitney U test for continuous values was used. Variables found to be statistically significant in univariate analyses were entered into multivariate analysis using a logistic regression model to identify independent risk factors for mortality. A two-tailed p value of <0.05 was considered statistically significant.
Results
A total of 3186 cases of DF/DHF were admitted to TTSH during the study period. Of these, 130 (4.1%) were diagnosed with DHF with seven dengue-associated deaths (case-fatality rate 5.4%).
The admission characteristics of the dengue-associated death cases compared to controls are shown in Table 1 . All controls were classified as having uncomplicated dengue fever. Of the dengue-associated death cases, five (71.4%) were male with a mean age of 47 years (range: 22-71); four patients (57.1%) were Chinese, two Malay (28.6%), and one Indian (14.3%). The main presenting complaint in all these patients was fever; other symptoms included confusion (28.6%), bleeding manifestations (gum bleeding, hematochezia) (42.9%), nausea and vomiting (57.1%), and abdominal pain (57.1%). Two patients (patients 3 and 7, Table 2 ) presented chiefly with neurological symptoms (localized weakness, confusion) and fever and had initial admitting diagnoses of cerebrovascular accidents. Two patients (patients 4 and 6) had fever, abdominal pain, and diarrhea as predominant symptoms and were admitted initially as infective gastroenteritis cases. Patient 1 was diabetic and presented in ketoacidosis. In four cases (57.1%), prominent abdominal pain and persistent vomiting preceded hypotension and clinical deterioration. No rash was noted in any of the cases at presentation. Three patients (42.8%) had pre-existing comorbidities including diabetes, hypertension, and hyperthyroidism. The mean number of days of illness prior to hospitalization was 4.8.
On admission, all dengue-associated death patients were febrile (mean 38.7 8C) and tachycardic. Blood pressure was low (SBP <100 mmHg) in only one patient and all had normal pulse pressure (>20 mmHg). Laboratory abnormalities on admission included: thrombocytopenia (71.4%; mean platelet count 71 Â 10 9 /L), coagulopathy (42.9%), leukopenia (28.6%), raised ALT or AST >3 times above normal (85.7%). Chest X-rays were abnormal in five cases (71.4%) with all showing bilateral interstitial patterns of disease. Dengue diagnosis was confirmed by PCR in four patients (serotype unavailable); dengue serology was performed in four patients, three with positive IgM alone and one with both positive IgG and IgM, consistent with primary and secondary dengue infection respectively (Table 2) . 6 Three patients were directly admitted to the intensive care unit (ICU). Clinical deterioration after admission was rapid in all cases and all patients required eventual transfer to the ICU within a mean of 2.4 days post-admission and at 5.6 days of fever. Transfer to the ICU was for hypotension in five patients (71.4%) and respiratory failure in two (28.6%). All patients received platelet and/or blood product transfusions. Two patients had evidence of depressed cardiac function (ejection fractions <30%) on bedside echocardiography. Causes of death in this series were: multi-organ failure with adult respiratory distress syndrome (57.1%), pneumonia and/or septicemia (57.1%), intracerebral hemorrhage (14.3%). No autopsy data were available.
On univariate analysis, confusion, absence of rash, tachycardia, and abnormalities in liver transaminases, creatinine, albumin, and prothrombin time were statistically more frequent in mortality-associated cases. On multivariate analysis, only tachycardia on admission was found to be independently associated with dengue mortality (OR = 3.56, 95% CI = 2.76-4.87, p = 0.036).
Discussion
This series of cases serves to characterize the mortality associated with adult dengue virus infection during an epidemic outbreak. Often considered more common in children, DHF is now being seen more frequently in older adults as a consequence of shifting patterns of infection and immunity. 4, 8, 9 Although the pathogenesis and pathophysiology of severe dengue infections remains incompletely understood, possible contributory factors to increased disease severity have been described. Age, 10 sex, 4 race, 11 pre-existing co-morbidities, 12 and viral-specific features 13 have been noted to play a role in disease outcomes by various authors. Vaughn and colleagues have previously shown that disease severity correlates to high dengue viremia titers and secondary infections. 14 It is postulated that the sequence of infecting dengue virus serotypes may be significant with respect to the risk of developing DHF and more severe disease, 15, 16 though all four dengue serotypes can cause DHF. 17 In 2003, DEN-2 was the predominant circulating strain in Singapore (80% of serotypes detected; overall dengue incidence 108.5 per 100 000 with six deaths); 5 however 2004 saw the introduction of DEN-1 as the major serotype and a resurgence of dengue (67% of circulating strains tested; overall dengue incidence 223 per 100 000 with eight deaths). 18 It is possible that this change in the predominant dengue strain and/or sequence of infections contributed towards the increase in DHF and more severe outcomes seen, though this remains unproven. Further, at least three of the fatal cases in this series had evidence of primary dengue infection on serology. This is in contrast to other reports that have described mortality and severe disease occurring predominantly in secondary infection. 4, 11, 16, 19 The mortality rate in cases complicated by hemorrhage is three to four times greater than that in those without bleeding manifestations. 7 Mortality is usually linked to delayed provision of supportive treatment and/or pre-morbid chronic illness. 7 In this series, though the average duration of illness prior to admission and presence of co-morbidities was not signifi-cantly different from controls, most patients had a fulminant course or presented at a far advanced stage of illness. Clinical deterioration occurred on average at day 4 with patients entering the intensive care unit at a mean of day 5.6 of fever. This clinical course is similar to that classically described in DHF/DSS 7, 19 and in other series on adult dengue mortality. 4, 8, 20 Although good early predictors of severity are presently lacking, warning symptoms such as abdominal pain and vomiting were noted in the majority of the severe cases prior to clinical deterioration. This is a well-recognized feature of severe plasma leakage and impending shock and when it occurs around the period of fever defervescence, should prompt closer monitoring and treatment. 7 Further, the prolongation of prothrombin time (PT) seen in mortalityassociated cases in this series is consistent with the coagulopathy and abnormalities in the tissue-factor pathway seen in severe dengue cases [21] [22] [23] and should warrant prompt correction and support. Autopsy studies demonstrate that patients who succumb to DHF do so from acute physiologic reactions caused by vascular permeability and inflammation. 20, 24 The mainstay of treatment remains prompt fluid resuscitation to counteract massive plasma leakage. Timely and effective intravenous crystalloid replacement of plasma losses results in a favorable outcome in most cases. 25, 26 Reversing shock and electrolyte abnormalities help prevent the onset of disseminated intravascular coagulation. 7 However the use of preventive blood transfusion in DHF/DSS especially during the plasma leakage phase may be deleterious 27 and might contribute to increased incidence of pulmonary edema and congestive heart failure. Its routine role in the clinical management of severe dengue infection merits further study and review.
As this series demonstrates, fatal DHF/DSS does occur in adults and in primary dengue infection. A minority of patients will still progress into fatal DHF/DSS and intractable coagulopathy despite receipt of current supportive measures, highlighting the need for improved clinical interventions and early predictors of disease severity.
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